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Lon is a nuclear-encoded, mitochondrial ATP-dependent protease
that degrades oxidized damaged proteins, assists protein folding
and participates in maintaining mitochondrial DNA levels. Lon is
upregulated at the mRNA level by several stressors, including (but
not limited to) ROS, heat shock and hypoxia. However, we have
observed that in many cases changes in mRNA levels, protein levels
and activity are not directly correlated, suggesting the possibility that
Lon activity could be regulated at post transcriptional and transla-
tional level. Lysine acetylation has emerged as an important post
translational modiﬁcation used to regulate mitochondrial proteins.
While acetylation within mitochondria is basically a non enzymatic
process, lysine deacetylation is carried out by sirtuins, a class of
NAD+-dependent class III histone deacetylases. Thus, we hypothe-
sized that Lon activity could be regulated by Sirt3, the most
important mitochondrial sirtuin. We ﬁrst analysed the colocalization
of Lon and Sirt3 in mitochondria by confocal microscopy, in three
different human cell lines (MCF7, RKO, HepG2). The two proteins
colocalize, with an estimation of 70% of colocalization signal. In
hypoxic conditions, or under oxidative stress, the colocalization
signal increased to 80%, at least in RKO cells. Coimmunoprecipitation
experiments conﬁrmed a direct interaction between Lon and Sirt3,
both in basal conditions, and in the conditions of hypoxia or
oxidative stress. While silencing of Lon did not alter Sirt3 levels,
silencing of Sirt3 caused a marked increase of Lon acetylation,
suggesting that Lon is a target of Sirt3 deacetylation activity. An in
silico analysis of Lon primary sequence indicated K357, K361 and
K917 as possible acetylation targets. We focused our attention on
K917, a Lys on the surface of the catalytic domain of Lon. Protein-
protein docking analysis suggested that acetylated K917 can enter
the cavity of Sirt3 known to be involved in the deacetylation of the
Ac-ACS peptide – a substrate proved to be deacetylated by Sirt3 –
and that the same residues involved in the binding and deacetylation
of this substrate are involved in interactions with Lon. In conclusion,
Lon appeared to be a substrate of Sirt3, and its proteolytic activity
could be regulated by the acetylation status of K917.
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The cellular energy metabolism, and mitochondria in partic-
ular, is becoming a prominent target for the development of
new anticancer strategies [1]. Agents acting on mitochondria,
termed “mitocans”, include compounds that affect a variety of
mitochondrial functions [2]. Some of them are currently
undergoing clinical trials. Among the drugs under evaluation
are 2-deoxy-d-glucose, 3-bromopyruvate, etomoxir or metfor-
min. However, most of these agents are not normally very
effective when used in monotherapy and thus, their clinical use
may be restricted to combined therapies as radio- and chemo-
sensitizing drugs. Arsenic trioxide (ATO, Trisenox) is a clinically
established drug for the treatment of acute promyelocytic
leukemia [3] and also of possible interest against other
neoplastic diseases [4]. However, its efﬁcacy is frequently
limited by the requirement of high doses to effectively induce
apoptosis. We have analyzed the chemo-sensitizing efﬁcacy of
different mitocans to ATO in HL60 cells, a human acute myeloid
leukemia cell line characterized as poorly sensitive to this drug.
We show that the above-mentioned mitocans potentiate the
lethality of ATO and we analyze the biochemical basis of their
chemo-sensitizing action.
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Western diet is characterized by a high content of fats and
carbohydrates and a limited intake of plant products. Nutrient
overload (increased free fatty acids and glucose intake) leads to
metabolic disorders such as insulin resistance, type 2 diabetes and
obesity. FFAs are more than substrates for oxidative metabolism
playing a signiﬁcant role in cell signaling; they inﬂuence enzymatic
activities, gene expression, ion homeostasis, etc. Excess of fatty
acids accompanied by triglyceride accumulation in multiple tissues
including adipocytes and pancreatic beta cells results in chronic
cellular injury and dysfunction. FFAs increase mitochondrial gener-
ation of ROS by depolarization of the mitochondrial inner membrane
due to the uncoupling effect. The aim of the study was to investigate
the effect of selected free fatty acids on mitochondrial function
in murine pancreatic beta cells and human preadipocytes. As an
experimental model mouse beta cells (BTC6) line and immortal-
ized human preadipocyte cell line (Chub-S7) was selected. The
cells were incubated for 24 h with different concentration of
FFAs (PA, AA, EPA). Chub-S7 cells were incubated with lower
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concentration of FFAs than BTC-6, due to the increased sensitivity
of these cells. Mitochondrial function was monitored by measure-
ments of the mitochondrial oxygen consumption (high-resolution
respirometry), ATP content (PerkinElmer), mitochondrial mem-
brane potential [ﬂow cytometry (BD)], activity of the caspase-9
(R&D Systems) and ROS generation (DCFH-DA). In preadipocyte
cell line: palmitic acid impaired mitochondrial function that was
manifested by a decreased intracellular ATP content and an
increased ROS generation. Arachidonic acid increased ROS gener-
ation and caspase-9 activity related with the mitochondrial
apoptosis pathway. Eicosapentaenoic acid decreased mitochon-
drial respiration and ATP content. In BTC6 line increased
the amount of early apoptotic cells after incubation with AA and
EPA was observed. There was also a tendency to increased
caspase-9 activity after incubation with FFAs. Arachidonic acid
slightly increased mitochondrial respiration in beta cells. In
conclusion, free fatty acids affect mitochondrial function of
selected adipose and pancreatic cell lines which is interesting in
the light of a recent data, indicating that regulation of mitochon-
drial activity may be the target pathway for treating obesity.
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Systemic energy metabolism requires coordination of different
organs to maintain homeostasis and overcome physiological and
stress challenges. Skeletal muscle is a major metabolic organ that
responds to energy shortage. Here, we show that nutrient depriva-
tion of cultured muscle cells (C2C12) changes their bioenergetic
proﬁle. Differentiated myotubes were deprived of glucose and l-
glutamine for 30 min up to 24 h. Plate-based respirometry showed
that the lack of glycolysis was ﬁrst compensated by an increased
mitochondrial ATP turnover. In the sequelae of nutrient deprivation,
mitochondrial respiration and ATP production were progressively
compromised until reaching levels below reliable detection after
24 h. After 8 h of nutrient deprivation, respiration linked to ATP
synthesis was decreased to 36% of non-fasted controls. Fibroblast
Growth Factor 21 (FGF21), previously shown to be induced upon a
reduced mitochondrial energy output in muscle mediating endocrine
crosstalk between organs, increased mRNA levels by 13-fold and the
secretion of FGF21 protein by 5-fold. Under these conditions, we
assessed the protein secretome unbiased using mass spectrometric
analysis. In the complex secretome, we found the highest released
protein to be FGF21, conﬁrming the suitability of our analysis to
discover novel players mediating fasting induced systemic crosstalk.
We identiﬁed a total of 1498 proteins; 93 of these were signiﬁcantly
induced by starvation, of which 21 were previously published to be
secreted and thus represent potential myokines. While FGF21
regulates carbohydrate and lipid metabolism, other novel proteins
may display similar effects to maintain systemic homeostasis and will
be explored in vivo, offering novel therapeutics to treat metabolic
diseases.
doi:10.1016/j.bbabio.2014.05.025
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The vast majority of mitochondrial proteins are encoded in the
nucleus; therefore they have to be imported from the cytosol to their
place of destination. The efﬁciency of their import into mitochondria
depends on the wide variety of proteins forming translocases
localized in both mitochondrial membranes. One of these trans-
locases is the TOM complex (translocase of the outer membrane)
regarded as the main gate into mitochondria for imported proteins.
The complex is responsible for decoding of targeting signals,
translocation of imported proteins across or into the outer
membrane, and their subsequent sorting. Thus, undoubtedly the
TOM complex is fundamental for mitochondrial functioning. The
subunit organization of the TOM complex has been shown to be
characteristic for a given phylogenetic lineage. Beside common
subunits the complex may contain subunit(s) that is(are) not
present in representatives of other phylogenetic lineages. Till now
the complex has been described for representatives of fungi and
animals (classiﬁed as Opisthokonta in the recent eukaryotic
classiﬁcation system) as well as for plants (Archaeplastida).
However, for representatives of Amoebozoa, Chromalveolata,
Excavata and Rhizaria (former Protista) the amount of data
concerning the complex is indeed small. Therefore we decided to
study the TOM complex of the amoeba Acanthamoeba castellanii
classiﬁed as a representative of Amoebozoa. This organism is also
quaint from the bioenergetics point of view because its mitochon-
dria share many features with both plant and animal mitochondria.
Consequently, studies of the amoeba TOM complex may contribute
to better understanding of evolution of mitochondria protein
import machinery. Here we report isolation of A. castellanii
functional TOM complex by afﬁnity chromatography using antibody
directed against A. castellanii Tom40. Apparent molecular mass of the
complex determined by native protein electrophoresis is 450 kDa.
The channel activity estimated for the complex supports its
identiﬁcation as the TOM complex. The complex subunits, identiﬁed
due to application of protein electrophoresis and mass spectrometry,
correspond to Tom40, Tom7 and Tom20. Thus, the isolated complex
can be used for veriﬁcation of the presence of other subunits
indicated by A. castellanii transcriptome analysis. The studies were
supported by NCN N N303 143937.
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